Motavizumab

Tax included
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.
MedChemExpress 
HY-P99209

Data sheet

Size
Multiple sizes
Reactivity
RSV
Application
COVID-19-anti-virus
CAS
677010-34-3